Tallac Therapeutics

866 Malcolm Rd Ste 100
Burlingame, CA 94010

Tallac Therapeutics is a privately held biopharmaceutical company based in Burlingame, California, focused on harnessing both innate and adaptive immunity to develop innovative cancer therapies through antibody drug conjugates (ADCs). Their pipeline features advanced oligonucleotide-based ADC candidates, including novel Toll-like Receptor Agonist Antibody Conjugates (TRAAC), designed to deliver TLR9 agonists that activate immune responses within the tumor microenvironment.

With several TRAAC molecules in various stages of discovery and clinical development, Tallac is making significant strides in the field of cancer immunotherapy. The company has garnered recognition for its pioneering efforts, being highlighted as one of the leading innovators in the development of next-generation therapies that combine precision medicine with systemic delivery.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

United StatesCaliforniaBurlingameTallac Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.